v3.26.1
Description of the Business and Financial Condition (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2026
Jun. 30, 2025
Jan. 31, 2025
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Feb. 28, 2026
Jun. 30, 2024
Subsidiary, Sale of Stock [Line Items]                      
Accumulated deficit             $ (253,712,000)   $ (233,672,000)    
Stock issuance costs       $ 400,000              
Cash and cash equivalents   $ 22,088,000     $ 22,088,000   23,480,000 $ 22,088,000 $ 18,563,000    
Senior Secured Convertible Promissory Note                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares of common stock to purchase (up to) (in shares)   103,225     103,225     103,225      
Exercise price (in dollars per share)   $ 7.75     $ 7.75     $ 7.75      
Warrants, contractual term (in years)   5 years     5 years     5 years      
Debt instrument, face amount   $ 10,000,000.0     $ 10,000,000.0     $ 10,000,000.0      
Proceeds from issuance of long-term debt   $ 9,900,000                  
January Common Warrants                      
Subsidiary, Sale of Stock [Line Items]                      
Issuance of common stock, net of issuance costs (in shares)     1,261,830                
Number of shares of common stock to purchase (up to) (in shares)     1,261,830                
Warrants, contractual term (in years)     5 years                
Common Stock                      
Subsidiary, Sale of Stock [Line Items]                      
Issuance of common stock, net of issuance costs (in shares)         281,697            
Proceeds from issuance of common stock     $ 9,200,000                
Common Stock | January Common Warrants                      
Subsidiary, Sale of Stock [Line Items]                      
Share price (in dollars per share)     $ 7.925                
Exercise price (in dollars per share)     $ 7.80                
Proceeds from issuance of common stock     $ 9,200,000                
2024 Registration Statement                      
Subsidiary, Sale of Stock [Line Items]                      
Sale of stock, aggregate initial offering price                     $ 200,000,000
At-The-Market Equity Offering Sales Agreement 2024                      
Subsidiary, Sale of Stock [Line Items]                      
Sale of stock, aggregate initial offering price                     $ 40,000,000
At-The-Market Equity Offering Sales Agreement 2024 | Common Stock                      
Subsidiary, Sale of Stock [Line Items]                      
Shares sold in offering (in shares) 699,678             388,520 1,717,507    
Share price (in dollars per share) $ 9.52 $ 7.34   $ 9.52 $ 7.34     $ 7.34 $ 9.46    
Net proceeds $ 6,700,000             $ 2,900,000 $ 16,200,000    
2026 Registration Statement                      
Subsidiary, Sale of Stock [Line Items]                      
Sale of stock, aggregate initial offering price                   $ 400,000,000  
At-The-Market Equity Offering Sales Agreement 2026                      
Subsidiary, Sale of Stock [Line Items]                      
Sale of stock, aggregate initial offering price                   $ 100,000,000  
Stock issuance costs             $ 200,000        
At-The-Market Equity Offering Sales Agreement 2026 | Common Stock                      
Subsidiary, Sale of Stock [Line Items]                      
Shares sold in offering (in shares)             3,378,094        
Share price (in dollars per share)             $ 5.48        
Net proceeds             $ 17,900,000        
Net proceeds             $ 17,700,000        
At-the-Market Offering | Common Stock                      
Subsidiary, Sale of Stock [Line Items]                      
Shares sold in offering (in shares)             4,077,772        
Share price (in dollars per share)             $ 6.18        
Net proceeds             $ 24,400,000        
Issuance of common stock, net of issuance costs (in shares)       819,157   106,823